Suppr超能文献

人类基因组编辑:如何防范恶意行为者。

Human genome editing: how to prevent rogue actors.

作者信息

Townsend Beverley A

机构信息

School of Law, University of KwaZulu-Natal, Durban, South Africa.

出版信息

BMC Med Ethics. 2020 Oct 6;21(1):95. doi: 10.1186/s12910-020-00527-w.

Abstract

BACKGROUND

Human genome editing technologies offer much potential benefit. However, central to any conversation relating to the application of such technologies are certain ethical, legal, and social difficulties around their application. The recent misuse, or inappropriate use, by certain Chinese actors of the application of genome editing technologies has been, of late, well noted and described. Consequently, caution is expressed by various policy experts, scientists, bioethicists, and members of the public with regard to the appropriate use of human germline genome editing and its possible future effect on future generations.

MAIN TEXT

As concerns about the applications of heritable genome editing have grown, so too have the questions around what is to be done to curtail 'rogue actors'. This paper explores various ways in which to regulate genomic editing that are socially beneficial, while being cognisant of legal and ethical principles and rights values. This is done by evolving regulatory frameworks across jurisdictions in an attempt to raise issues, address common principles, and set responsible standards for stewardship of the novel technology.

CONCLUSIONS

It is suggested that robust and concrete regulatory measures be introduced that are culturally and contextually sensitive, inclusive, appropriate, and trustworthy - and are based on public empowerment and human rights objectives. Doing so will ensure that we are perfectly positioned to harness and promote the benefits that novel technologies have to offer, while safeguarding public health and curtailing the ambitions of rogue actors. This it is acknowledged is no easy task, so, as a point of departure, this paper sets out a path forward by means of certain, practical recommendations - by constructing genome editing regulation in a manner that both fulfils the desire to better progress human health and that can withstand legal and ethical scrutiny. The following observations and recommendations are made: Firstly, that a solution of effective, legitimate governance should consist of a combination of national and supranational legislative regulation or 'hard' law, in combination with 'soft' ethics, firmly anchored in and underpinned by human rights values. Second, that efforts to support legal and ethical solutions should be rigorous, practical, and robust, contribute to a reaffirmation of human rights in a contextually sensitive manner, and be transnational in reach. Lastly, that greater harmonisation across jurisdictions and increased public engagement be sought. This it is proposed will address the question of how to implement a normative framework which in turn can prevent future rogue actors.

摘要

背景

人类基因组编辑技术具有诸多潜在益处。然而,任何有关此类技术应用的讨论,其核心都涉及围绕其应用的某些伦理、法律和社会难题。近期,某些中国行为主体对基因组编辑技术应用的滥用或不当使用,近来已受到广泛关注和报道。因此,众多政策专家、科学家、生物伦理学家及公众对人类生殖系基因组编辑的恰当使用及其对后代可能产生的影响表示谨慎。

正文

随着对可遗传基因组编辑应用的担忧与日俱增,围绕如何遏制“不良行为者”的问题也日益凸显。本文探讨了各种对基因组编辑进行监管的方式,这些方式既有利于社会,又能兼顾法律和伦理原则以及权利价值观。这是通过在不同司法管辖区不断完善监管框架来实现的,旨在提出问题、探讨共同原则,并为这项新技术的管理设定负责任的标准。

结论

建议引入强有力且具体的监管措施,这些措施应在文化和背景方面具有敏感性、包容性、恰当性和可信度,并基于公众赋权和人权目标。这样做将确保我们能够充分利用和推广新技术带来的益处,同时保障公众健康并遏制不良行为者的企图。诚然,这并非易事,因此,作为出发点,本文通过某些切实可行的建议,规划了一条前进的道路——以一种既能满足推动人类健康取得更大进展的愿望,又能经受住法律和伦理审查的方式构建基因组编辑监管。以下是一些观察结果和建议:首先,有效的合法治理解决方案应包括国家和超国家立法监管或“硬”法与“软”伦理的结合,并牢固地扎根于人权价值观并以其为支撑。其次,支持法律和伦理解决方案的努力应严谨、务实且有力,以在具体情境中敏感的方式促进对人权的重申,且具有跨国影响力。最后,应寻求不同司法管辖区之间更大程度的协调以及公众更多的参与。建议这将解决如何实施一个规范性框架的问题,进而能够防止未来出现不良行为者。

相似文献

1
4
Governance of Heritable Human Gene Editing World-Wide and Beyond.人类可遗传基因编辑的全球治理及其他问题
Int J Environ Res Public Health. 2022 May 31;19(11):6739. doi: 10.3390/ijerph19116739.
8
Ordo-Responsibility for Germline Gene Editing.种系基因编辑的责任顺位
CRISPR J. 2020 Feb;3(1):37-43. doi: 10.1089/crispr.2019.0040.

引用本文的文献

3
CRISPR technology in human diseases.用于人类疾病治疗的CRISPR技术。
MedComm (2020). 2024 Jul 29;5(8):e672. doi: 10.1002/mco2.672. eCollection 2024 Aug.
4
Stakeholder Involvement in the Governance of Human Genome Editing in Japan.日本利益相关者对人类基因组编辑治理的参与。
Asian Bioeth Rev. 2023 Apr 26;15(4):431-455. doi: 10.1007/s41649-023-00251-8. eCollection 2023 Oct.

本文引用的文献

1
A global observatory for gene editing.一个基因编辑全球观测站。
Nature. 2018 Mar;555(7697):435-437. doi: 10.1038/d41586-018-03270-w.
3
CRISPR's unwanted anniversary.CRISPR不受欢迎的周年纪念。
Science. 2019 Nov 15;366(6467):777. doi: 10.1126/science.aba1751.
5
Rogues and Regulation of Germline Editing.生殖系编辑的乱象与监管
N Engl J Med. 2019 Mar 7;380(10):976-980. doi: 10.1056/NEJMms1817528. Epub 2019 Jan 16.
8
CRISPR Ethics: Moral Considerations for Applications of a Powerful Tool.CRISPR 伦理:对强大工具应用的道德考量。
J Mol Biol. 2019 Jan 4;431(1):88-101. doi: 10.1016/j.jmb.2018.05.044. Epub 2018 Jun 7.
10
Towards an ethics safe harbor for global biomedical research.迈向全球生物医学研究的伦理安全港。
J Law Biosci. 2014 Feb 14;1(1):3-51. doi: 10.1093/jlb/lst002. eCollection 2014 Mar.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验